<SEC-DOCUMENT>0001104659-16-132643.txt : 20160816
<SEC-HEADER>0001104659-16-132643.hdr.sgml : 20160816
<ACCEPTANCE-DATETIME>20160714161500
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-16-132643
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20160714

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CATABASIS PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001454789
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BLDG. 1400E, SUITE B14202
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		617-349-1971

	MAIL ADDRESS:	
		STREET 1:		ONE KENDALL SQUARE
		STREET 2:		BLDG. 1400E, SUITE B14202
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman"><img width="123" height="25" src="g142945bgi001.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman"><img width="103" height="49" src="g142945bgi002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">July&nbsp;14, 2016</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">By Electronic Submission</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Securities and Exchange Commission</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Division of Corporation Finance</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">100 F Street, N.E.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Washington, DC&#160; 20549</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Attention: Suzanne Hayes</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 24.5pt;text-indent:-24.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Re:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Catabasis Pharmaceuticals,&nbsp;Inc.<br> Registration Statement on Form&nbsp;S-3<br> Filed July&nbsp;1, 2016<br>  <u>File No.&nbsp;333-212382</u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Ladies and Gentlemen:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On behalf of Catabasis Pharmaceuticals,&nbsp;Inc. (the &#147;<u>Company</u>&#148;), filed herewith is Amendment No.&nbsp;1 (&#147;<u>Amendment No.&nbsp;1</u>&#148;) to the Registration Statement referenced above.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amendment No.&nbsp;1 is being submitted in response to a comment contained in a letter, dated July&nbsp;13, 2016 (the &#147;<u>Letter</u>&#148;), from Suzanne Hayes of the Staff (the &#147;<u>Staff</u>&#148;) of the Securities and Exchange Commission to Jill C. Milne, the Company&#146;s President and Chief Executive Officer.&#160; For convenient reference, we have set forth below in italics the Staff&#146;s comment set forth in the Letter and have keyed the Company&#146;s response to the numbering of the comment and the heading used in the Letter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prospectus Cover Page</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>It appears that you are relying on General Instruction I.B.6 of Form&nbsp;S-3 for this offering. If true, please revise your prospectus cover page&nbsp;to disclose the calculation of the aggregate market value of your outstanding voting and nonvoting common equity and the amount of all securities offered pursuant to General Instruction I.B.6 during the prior 12 calendar month period that ends on, and includes, the date of the prospectus. Refer to Instruction 7 to General Instruction I.B.6. Otherwise, please provide us your analysis demonstrating your eligibility to use Form&nbsp;S-3.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.5in;text-indent:-1.0in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Response:</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>In response to the Staff&#146;s comment, the Company has modified the disclosure on the prospectus cover page&nbsp;to include the aggregate market value of the Company&#146;s outstanding voting and non-voting common</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="720" height="38" src="g142945bgi003.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109502\16-14294-5\task8020066\14294-5-bg.htm',USER='109502',CD='Jul 14 07:06 2016' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt 1.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">equity, as well as the amount of all securities offered pursuant to General Instruction I.B.6 of Form&nbsp;S-3 during the prior 12 calendar month period that ends on, and includes, the date of the prospectus.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If you have any further questions or comments, or if you require any additional information, please contact the undersigned by telephone at (617) 526-6633 or facsimile at (617)&nbsp;526-5000.&#160; Thank you for your assistance.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very   truly yours,</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   Rosemary G. Reilly</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rosemary   G. Reilly</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">cc:</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Jill C. Milne, Catabasis Pharmaceuticals,&nbsp;Inc.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_064105_5218"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\109502\16-14294-5\task8020066\14294-5-bg.htm',USER='109502',CD='Jul 14 07:06 2016' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g142945bgi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g142945bgi001.jpg
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'HHHHHHK_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g142945bgi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g142945bgi002.jpg
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MGH .O%67T683/+$85E-S),'*YX:,J,^O.*J6&@7D;L\I2/,D38\S<0%5@3T
M'WA@"G:9H=W:EDD  ^SFV,OGECC^\!@8Y['GG\WKI=YY=NYLK-7M2@$:M_K@
MJD9)QQC.1U[TT^'99;><2K;[IK>9 F,K&7?=@<=!6M96)M+N[D 0),4*JHQC
1"X/\JNT444444444445__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g142945bgi003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g142945bgi003.jpg
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
